- call +1-201-465-4211
- email sales@mrinsights.biz
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
Scope of the Report:
This report focuses on the Biologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
The worldwide market for Biologics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
Market Segment by Applications, can be divided into
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
There are 15 Chapters to deeply display the global Biologics market.
Chapter 1, to describe Biologics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biologics, with sales, revenue, and price of Biologics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biologics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biologics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Biologics Introduction
1.2 Market Analysis by Type
1.2.1 Monoclonal Antibodies
1.2.2 Vaccines
1.2.3 Recombinant Proteins
1.2.4 Antisense
1.2.5 RNAi
1.3 Market Analysis by Applications
1.3.1 Infectious Diseases
1.3.2 Oncology
1.3.3 Immunology
1.3.4 Autoimmune Diseases
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly & Company
2.1.1 Business Overview
2.1.2 Biologics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly & Company Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Samsung Biologics
2.2.1 Business Overview
2.2.2 Biologics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Samsung Biologics Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 F Hoffman La Roche
2.3.1 Business Overview
2.3.2 Biologics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F Hoffman La Roche Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Celltrion
2.4.1 Business Overview
2.4.2 Biologics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Celltrion Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Addgene
2.5.1 Business Overview
2.5.2 Biologics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Addgene Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amgen
2.6.1 Business Overview
2.6.2 Biologics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Amgen Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbvie Inc.
2.7.1 Business Overview
2.7.2 Biologics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbvie Inc. Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Biologics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer Inc.
2.9.1 Business Overview
2.9.2 Biologics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Inc. Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Merck & Co. Inc.
2.10.1 Business Overview
2.10.2 Biologics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck & Co. Inc. Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Novo Nordisk A/S
2.11.1 Business Overview
2.11.2 Biologics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novo Nordisk A/S Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Johnson & Johnson Services Inc.
2.12.1 Business Overview
2.12.2 Biologics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Johnson & Johnson Services Inc. Biologics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Biologics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biologics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Biologics Manufacturer Market Share in 2017
3.3.2 Top 6 Biologics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Biologics Market Analysis by Regions
4.1 Global Biologics Sales, Revenue and Market Share by Regions
4.1.1 Global Biologics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Biologics Revenue and Market Share by Regions (2013-2018)
4.2 North America Biologics Sales and Growth Rate (2013-2018)
4.3 Europe Biologics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Biologics Sales and Growth Rate (2013-2018)
4.5 South America Biologics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Biologics Sales and Growth Rate (2013-2018)
5 North America Biologics by Countries
5.1 North America Biologics Sales, Revenue and Market Share by Countries
5.1.1 North America Biologics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Biologics Revenue and Market Share by Countries (2013-2018)
5.2 United States Biologics Sales and Growth Rate (2013-2018)
5.3 Canada Biologics Sales and Growth Rate (2013-2018)
5.4 Mexico Biologics Sales and Growth Rate (2013-2018)
6 Europe Biologics by Countries
6.1 Europe Biologics Sales, Revenue and Market Share by Countries
6.1.1 Europe Biologics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Biologics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Biologics Sales and Growth Rate (2013-2018)
6.3 UK Biologics Sales and Growth Rate (2013-2018)
6.4 France Biologics Sales and Growth Rate (2013-2018)
6.5 Russia Biologics Sales and Growth Rate (2013-2018)
6.6 Italy Biologics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Biologics by Countries
7.1 Asia-Pacific Biologics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biologics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Biologics Revenue and Market Share by Countries (2013-2018)
7.2 China Biologics Sales and Growth Rate (2013-2018)
7.3 Japan Biologics Sales and Growth Rate (2013-2018)
7.4 Korea Biologics Sales and Growth Rate (2013-2018)
7.5 India Biologics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Biologics Sales and Growth Rate (2013-2018)
8 South America Biologics by Countries
8.1 South America Biologics Sales, Revenue and Market Share by Countries
8.1.1 South America Biologics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Biologics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Biologics Sales and Growth Rate (2013-2018)
8.3 Argentina Biologics Sales and Growth Rate (2013-2018)
8.4 Colombia Biologics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Biologics by Countries
9.1 Middle East and Africa Biologics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biologics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Biologics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Biologics Sales and Growth Rate (2013-2018)
9.3 UAE Biologics Sales and Growth Rate (2013-2018)
9.4 Egypt Biologics Sales and Growth Rate (2013-2018)
9.5 Nigeria Biologics Sales and Growth Rate (2013-2018)
9.6 South Africa Biologics Sales and Growth Rate (2013-2018)
10 Global Biologics Market Segment by Type
10.1 Global Biologics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biologics Sales and Market Share by Type (2013-2018)
10.1.2 Global Biologics Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal Antibodies Sales Growth and Price
10.2.1 Global Monoclonal Antibodies Sales Growth (2013-2018)
10.2.2 Global Monoclonal Antibodies Price (2013-2018)
10.3 Vaccines Sales Growth and Price
10.3.1 Global Vaccines Sales Growth (2013-2018)
10.3.2 Global Vaccines Price (2013-2018)
10.4 Recombinant Proteins Sales Growth and Price
10.4.1 Global Recombinant Proteins Sales Growth (2013-2018)
10.4.2 Global Recombinant Proteins Price (2013-2018)
10.5 Antisense Sales Growth and Price
10.5.1 Global Antisense Sales Growth (2013-2018)
10.5.2 Global Antisense Price (2013-2018)
10.6 RNAi Sales Growth and Price
10.6.1 Global RNAi Sales Growth (2013-2018)
10.6.2 Global RNAi Price (2013-2018)
11 Global Biologics Market Segment by Application
11.1 Global Biologics Sales Market Share by Application (2013-2018)
11.2 Infectious Diseases Sales Growth (2013-2018)
11.3 Oncology Sales Growth (2013-2018)
11.4 Immunology Sales Growth (2013-2018)
11.5 Autoimmune Diseases Sales Growth (2013-2018)
12 Biologics Market Forecast (2018-2023)
12.1 Global Biologics Sales, Revenue and Growth Rate (2018-2023)
12.2 Biologics Market Forecast by Regions (2018-2023)
12.2.1 North America Biologics Market Forecast (2018-2023)
12.2.2 Europe Biologics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biologics Market Forecast (2018-2023)
12.2.4 South America Biologics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biologics Market Forecast (2018-2023)
12.3 Biologics Market Forecast by Type (2018-2023)
12.3.1 Global Biologics Sales Forecast by Type (2018-2023)
12.3.2 Global Biologics Market Share Forecast by Type (2018-2023)
12.4 Biologics Market Forecast by Application (2018-2023)
12.4.1 Global Biologics Sales Forecast by Application (2018-2023)
12.4.2 Global Biologics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Biologics Picture
Table Product Specifications of Biologics
Figure Global Sales Market Share of Biologics by Types in 2017
Table Biologics Types for Maj
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
